|
Frank E. O'Donnell Jr. MD. has been our Chairman of the Board and a Director on a full time basis since 2002. He is our former President and Chief Executive Officer. Dr. O'Donnell serves as managing director of The Hopkins Capital Group an affiliation of limited liability companies, which engage in private equity and venture capital investing in disruptive technologies in healthcare. He is a co-founder and chairman of RetinaPharma Technologies Inc. which now includes Tatton Technologies LLC and a co-founder of Biotech Specialty Partners LLC an alliance of specialty pharmaceutical and biotechnology companies. He serves as Chairman and CEO of Accentia Biopharmaceuticals Inc. Dr. O'Donnell is a graduate of The Johns Hopkins School of Medicine and received his residency training at the Wilmer Ophthalmological Institute Johns Hopkins Hospital. Dr. O'Donnell is a former professor and Chairman of the Department of Ophthalmology St. Louis University School of Medicine. Dr. O'Donnell holds 34 U.S. Patents. Dr. O'Donnell is the 2000 Recipient of the Jules Stein Vision Award sponsored by Retinitis Pigmentosa International. He is a trustee of the Health Careers Foundation and of St Louis University.
| 